0001209191-23-004567.txt : 20230124 0001209191-23-004567.hdr.sgml : 20230124 20230124160055 ACCESSION NUMBER: 0001209191-23-004567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230120 FILED AS OF DATE: 20230124 DATE AS OF CHANGE: 20230124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tray Thomas CENTRAL INDEX KEY: 0001912317 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 23548134 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-20 0 0000879169 INCYTE CORP INCY 0001912317 Tray Thomas 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 Principal Accounting Officer Common Stock 2023-01-20 4 A 0 2833 0.00 A 19439 D Employee Stock Option (right to buy) 83.20 2023-01-20 4 A 0 2968 0.00 A 2033-01-19 Common Stock 2968 2968 D Represents award of restricted stock units ("RSUs") that will vest 100% on the fourth anniversary of the award, subject to Thomas Tray's continued service with the issuer through the applicable vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis. Includes an aggregate of 15,080 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The aggregate amount also includes the additional restricted stock granted on January 20, 2023. Beginning January 20, 2023, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2023 after one year and the remainder vesting monthly over three years. /s/ Elizabeth Feeney, Attorney-In-Fact 2023-01-24